Cambridge Heart shares jump 35% after the company reports its 3rd quarter results, narrowing its losses by 16.6%.
Cambridge Heart (NSDQ:CAMH) remained in the red in its 3rd quarter after the company restructured its operations in July, but narrowed its losses by 16.6%.
The Tewksbury, Mass.-based healthcare company posted $1.1 million in net loss, or 1¢ per share on sales of $420,000 million for the 3 months ended Sept. 30. That compared with a net loss of $1.3 million, or 1¢ per share on sales of $480,000 million during the same period last year. The earnings per share met analysts' estimate.